SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Target Corp – ‘10-K’ for 1/30/16 – ‘EX-10.Y’

On:  Friday, 3/11/16, at 1:48pm ET   ·   For:  1/30/16   ·   Accession #:  27419-16-43   ·   File #:  1-06049

Previous ‘10-K’:  ‘10-K’ on 3/13/15 for 1/31/15   ·   Next:  ‘10-K’ on 3/8/17 for 1/28/17   ·   Latest:  ‘10-K’ on 3/13/24 for 2/3/24   ·   6 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/11/16  Target Corp                       10-K        1/30/16  161:16M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.01M 
 2: EX-10.AA    Material Contract                                   HTML     51K 
 3: EX-10.KK    Material Contract                                   HTML    294K 
 4: EX-10.LL    Material Contract                                   HTML     43K 
 5: EX-10.MM    Material Contract                                   HTML     66K 
 6: EX-10.W     Material Contract                                   HTML     74K 
 7: EX-10.X     Material Contract                                   HTML     75K 
 8: EX-10.Y     Material Contract                                   HTML     73K 
10: EX-21       Subsidiaries List                                   HTML     41K 
11: EX-23       Consent of Experts or Counsel                       HTML     44K 
12: EX-24       Power of Attorney                                   HTML    101K 
 9: EX-12       Statement re: Computation of Ratios                 HTML     53K 
13: EX-31.A     Certification -- §302 - SOA'02                      HTML     48K 
14: EX-31.B     Certification -- §302 - SOA'02                      HTML     48K 
15: EX-32.A     Certification -- §906 - SOA'02                      HTML     43K 
16: EX-32.B     Certification -- §906 - SOA'02                      HTML     43K 
23: R1          Document and Entity Information                     HTML     69K 
24: R2          Consolidated Statements of Operations               HTML    114K 
25: R3          Consolidated Statements of Comprehensive Income     HTML     58K 
26: R4          Consolidated Statements of Comprehensive Income     HTML     47K 
                (Parenthetical)                                                  
27: R5          Consolidated Statements of Financial Position       HTML    135K 
28: R6          Consolidated Statements of Financial Position       HTML     65K 
                (Parenthetical)                                                  
29: R7          Consolidated Statements of Cash Flows               HTML    166K 
30: R8          Consolidated Statements of Cash Flows               HTML     45K 
                (Parenthetical)                                                  
31: R9          Consolidated Statements of Shareholders'            HTML     88K 
                Investment                                                       
32: R10         Consolidated Statements of Shareholders'            HTML     46K 
                Investment (Parenthetical)                                       
33: R11         Summary of Accounting Policies                      HTML     51K 
34: R12         Revenues                                            HTML     46K 
35: R13         Cost of Sales and Selling, General and              HTML     49K 
                Administrative Expenses                                          
36: R14         Consideration Received from Vendors                 HTML     45K 
37: R15         Advertising Costs                                   HTML     52K 
38: R16         Pharmacies and Clinics Transactions (Notes)         HTML    122K 
39: R17         Canada Exit                                         HTML    122K 
40: R18         Restructuring Initiatives                           HTML     63K 
41: R19         Credit Card Receivables Transaction                 HTML     45K 
42: R20         Fair Value Measurements                             HTML     87K 
43: R21         Cash Equivalents                                    HTML     47K 
44: R22         Inventory                                           HTML     47K 
45: R23         Other Current Assets                                HTML     55K 
46: R24         Property and Equipment                              HTML     60K 
47: R25         Other Noncurrent Assets                             HTML     54K 
48: R26         Goodwill and Intangible Assets                      HTML     80K 
49: R27         Accounts Payable                                    HTML     44K 
50: R28         Accrued and Other Current Liabilities               HTML     60K 
51: R29         Commitments and Contingencies                       HTML     71K 
52: R30         Notes Payable and Long-Term Debt                    HTML     81K 
53: R31         Derivative Financial Instruments                    HTML     92K 
54: R32         Leases                                              HTML     85K 
55: R33         Income Taxes                                        HTML    115K 
56: R34         Other Noncurrent Liabilities                        HTML     56K 
57: R35         Share Repurchase                                    HTML     55K 
58: R36         Share-Based Compensation                            HTML    113K 
59: R37         Defined Contribution Plans                          HTML     71K 
60: R38         Pension and Postretirement Health Care Plans        HTML    231K 
61: R39         Accumulated Other Comprehensive Income              HTML     65K 
62: R40         Segment Reporting                                   HTML     94K 
63: R41         Quarterly Results (Unaudited)                       HTML    249K 
64: R42         Summary of Accounting Policies (Policies)           HTML    157K 
65: R43         Advertising Costs (Tables)                          HTML     52K 
66: R44         Pharmacies and Clinics Transactions (Tables)        HTML     83K 
67: R45         Canada Exit (Tables)                                HTML    101K 
68: R46         Restructuring Initiatives (Tables)                  HTML     65K 
69: R47         Fair Value Measurements (Tables)                    HTML     85K 
70: R48         Other Current Assets (Tables)                       HTML     55K 
71: R49         Property and Equipment (Tables)                     HTML     59K 
72: R50         Other Noncurrent Assets (Tables)                    HTML     54K 
73: R51         Goodwill and Intangible Assets (Tables)             HTML     74K 
74: R52         Accrued and Other Current Liabilities (Tables)      HTML     60K 
75: R53         Commitments and Contingencies (Tables)              HTML     60K 
76: R54         Notes Payable and Long-Term Debt (Tables)           HTML     83K 
77: R55         Derivative Financial Instruments (Tables)           HTML     87K 
78: R56         Leases (Tables)                                     HTML     80K 
79: R57         Income Taxes (Tables)                               HTML    111K 
80: R58         Other Noncurrent Liabilities (Tables)               HTML     55K 
81: R59         Share Repurchase (Tables)                           HTML     51K 
82: R60         Share-Based Compensation (Tables)                   HTML    113K 
83: R61         Defined Contribution Plans (Tables)                 HTML     69K 
84: R62         Pension and Postretirement Health Care Plans        HTML    242K 
                (Tables)                                                         
85: R63         Accumulated Other Comprehensive Income (Tables)     HTML     62K 
86: R64         Segment Reporting (Tables)                          HTML     89K 
87: R65         Quarterly Results (Unaudited) (Tables)              HTML    250K 
88: R66         Summary of Accounting Policies (Details)            HTML     46K 
89: R67         Revenues (Details)                                  HTML     51K 
90: R68         Advertising Costs (Details)                         HTML     48K 
91: R69         Pharmacies and Clinics Transactions - Narrative     HTML     67K 
                (Details)                                                        
92: R70         Pharmacies and Clinics Transactions - Schedule of   HTML     69K 
                Gain on Pharmacies and Clinics Transaction                       
                (Details)                                                        
93: R71         Pharmacies and Clinics Transactions - Schedule of   HTML     59K 
                Pharmacy and Clinic Inventory and Other Assets                   
                (Details)                                                        
94: R72         Canada Exit - Narrative (Details)                   HTML     69K 
95: R73         Canada Exit - Schedule of Income/(Loss) on          HTML     79K 
                Discontinued Operations (Details)                                
96: R74         Canada Exit - Schedule of Pretax Exit Costs         HTML     53K 
                (Details)                                                        
97: R75         Canada Exit - Schedule of Assets and Liabilities    HTML     60K 
                of Discontinued Operations (Details)                             
98: R76         Restructuring Initiatives - Schedule of             HTML     57K 
                Restructuring Costs (Details)                                    
99: R77         Restructuring Initiatives - Schedule of             HTML     59K 
                Restructuring-Related Liabilities (Details)                      
100: R78         Credit Card Receivables Transaction (Details)       HTML     53K  
101: R79         Fair Value Measurements - Schedule of Fair Value    HTML     76K  
                Measurements - Recurring Basis (Details)                         
102: R80         Fair Value Measurements - Schedule of Significant   HTML     48K  
                Financial Instruments not Measured at Fair Value                 
                (Details)                                                        
103: R81         Cash Equivalents (Details)                          HTML     49K  
104: R82         Inventory (Details)                                 HTML     43K  
105: R83         Other Current Assets (Details)                      HTML     58K  
106: R84         Property and Equipment (Details)                    HTML     66K  
107: R85         Other Noncurrent Assets (Details)                   HTML     55K  
108: R86         Goodwill and Intangible Assets - Narrative          HTML     83K  
                (Details)                                                        
109: R87         Goodwill and Intangible Assets - Schedule of        HTML     54K  
                Intangible Assets (Details)                                      
110: R88         Goodwill and Intangible Assets - Schedule of        HTML     53K  
                Estimated Amortization Expense (Details)                         
111: R89         Accounts Payable (Details)                          HTML     45K  
112: R90         Accrued and Other Current Liabilities (Details)     HTML     69K  
113: R91         Commitments and Contingencies - Narrative           HTML     74K  
                (Details)                                                        
114: R92         Commitments and Contingencies - Schedule of         HTML     57K  
                Expenses Incurred and Amounts Accrued (Details)                  
115: R93         Notes Payable and Long-Term Debt - Narrative        HTML     73K  
                (Details)                                                        
116: R94         Notes Payable and Long-Term Debt - Schedule of      HTML     71K  
                Carrying Value and Maturities of Debt Portfolio                  
                (Details)                                                        
117: R95         Notes Payable and Long-Term Debt - Schedule of      HTML     55K  
                Required Principal Payments (Details)                            
118: R96         Notes Payable and Long-Term Debt - Schedule of      HTML     52K  
                Commercial Paper (Details)                                       
119: R97         Derivative Financial Instruments - Narrative        HTML     63K  
                (Details)                                                        
120: R98         Derivative Financial Instruments - Schedule of      HTML     63K  
                Outstanding Interest Rate Swap Summary (Details)                 
121: R99         Derivative Financial Instruments - Schedule of      HTML     63K  
                Classification and Fair Value (Details)                          
122: R100        Derivative Financial Instruments - Schedule of      HTML     46K  
                Derivative Contracts - Effect on Results of                      
                Operations (Details)                                             
123: R101        Leases - Narrative (Details)                        HTML     68K  
124: R102        Leases - Schedule of Rent Expense (Details)         HTML     48K  
125: R103        Leases - Schedule of Future Minimum Lease Payments  HTML    111K  
                (Details)                                                        
126: R104        Income Taxes - Narrative (Details)                  HTML     83K  
127: R105        Income Taxes - Schedule of Tax Rate Reconciliation  HTML     61K  
                - Continuing Operations (Details)                                
128: R106        Income Taxes - Schedule of Provision for Income     HTML     78K  
                Taxes (Details)                                                  
129: R107        Income Taxes - Schedule of Net Deferred Tax         HTML     74K  
                Asset/(Liability) (Details)                                      
130: R108        Income Taxes - Schedule of Reconciliation of        HTML     54K  
                Liability for Unrecognized Tax Benefits (Details)                
131: R109        Other Noncurrent Liabilities (Details)              HTML     59K  
132: R110        Share Repurchase - Narrative (Details)              HTML     67K  
133: R111        Share Repurchase - Schedule of Share Repurchases    HTML     48K  
                (Details)                                                        
134: R112        Share-Based Compensation - Narrative (Details)      HTML     96K  
135: R113        Share-Based Compensation - Schedule of Restricted   HTML     75K  
                Stock Activity and Performance Share Unit Activity               
                (Details)                                                        
136: R114        Share-Based Compensation - Schedule of Stock        HTML     76K  
                Option Activity (Details)                                        
137: R115        Share-Based Compensation - Schedule of Stock        HTML     49K  
                Option Exercises (Details)                                       
138: R116        Defined Contribution Plans (Details)                HTML     89K  
139: R117        Pension and Postretirement Health Care Plans -      HTML     92K  
                Narrative (Details)                                              
140: R118        Pension and Postretirement Health Care Plans -      HTML     69K  
                Schedule of Change in Projected Benefit Obligation               
                (Details)                                                        
141: R119        Pension and Postretirement Health Care Plans -      HTML     71K  
                Schedule of Change in Plan Assets (Details)                      
142: R120        Pension and Postretirement Health Care Plans -      HTML     60K  
                Schedule of Recognition of Funded/(Underfunded)                  
                Status (Details)                                                 
143: R121        Pension and Postretirement Health Care Plans -      HTML     52K  
                Schedule of Amounts in Accumulated Other                         
                Comprehensive Income (Details)                                   
144: R122        Pension and Postretirement Health Care Plans -      HTML     72K  
                Schedule of Change in Accumulated Other                          
                Comprehensive Income (Details)                                   
145: R123        Pension and Postretirement Health Care Plans -      HTML     56K  
                Schedule of Expected Amortization of Amounts in                  
                Accumulated Other Comprehensive Income (Details)                 
146: R124        Pension and Postretirement Health Care Plans -      HTML     63K  
                Schedule of Net Pension Benefit Expense (Details)                
147: R125        Pension and Postretirement Health Care Plans -      HTML     53K  
                Schedule of Defined Benefit Pension Plan                         
                Information (Details)                                            
148: R126        Pension and Postretirement Health Care Plans -      HTML     47K  
                Schedule of Benefit Obligation Weighted Average                  
                Assumptions (Details)                                            
149: R127        Pension and Postretirement Health Care Plans -      HTML     51K  
                Schedule of Net Periodic Benefit Expense Weighted                
                Average Assumptions (Details)                                    
150: R128        Pension and Postretirement Health Care Plans -      HTML     60K  
                Schedule of Asset Category (Details)                             
151: R129        Pension and Postretirement Health Care Plans -      HTML     68K  
                Schedule of Fair Value Measurements (Details)                    
152: R130        Pension and Postretirement Health Care Plans -      HTML     56K  
                Schedule of Estimated Future Benefit Payments                    
                (Details)                                                        
153: R131        Accumulated Other Comprehensive Income (Details)    HTML     79K  
154: R132        Segment Reporting - Schedule of Business Segment    HTML     78K  
                Results (Details)                                                
155: R133        Segment Reporting - Narrative (Details)             HTML     51K  
156: R134        Segment Reporting - Schedule of Total Assets by     HTML     50K  
                Segments (Details)                                               
157: R135        Quarterly Results (Unaudited) - Schedule of         HTML    118K  
                Quarterly Results (Details)                                      
158: R136        Quarterly Results (Unaudited) - Summary of Sales    HTML     63K  
                by Product Category (Details)                                    
160: XML         IDEA XML File -- Filing Summary                      XML    290K  
159: EXCEL       IDEA Workbook of Financial Reports                  XLSX    150K  
17: EX-101.INS  XBRL Instance -- tgt-20160130                        XML   4.14M 
19: EX-101.CAL  XBRL Calculations -- tgt-20160130_cal                XML    425K 
20: EX-101.DEF  XBRL Definitions -- tgt-20160130_def                 XML   1.01M 
21: EX-101.LAB  XBRL Labels -- tgt-20160130_lab                      XML   2.99M 
22: EX-101.PRE  XBRL Presentations -- tgt-20160130_pre               XML   1.70M 
18: EX-101.SCH  XBRL Schema -- tgt-20160130                          XSD    348K 
161: ZIP         XBRL Zipped Folder -- 0000027419-16-000043-xbrl      Zip    395K  


‘EX-10.Y’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  
Exhibit (10)Y


Amended and Restated Target Corporation 2011 Long-Term Incentive Plan

EXECUTIVE
PERFORMANCE SHARE UNIT AGREEMENT
THIS PERFORMANCE SHARE UNIT AGREEMENT (the “Agreement”) is made in Minneapolis, Minnesota as of the date of grant (the “Grant Date”) set forth in the award letter (the “Award Letter”) by and between the Company and the person (the “Executive”) identified in the Award Letter. This award (the “Award”) of Performance Share Units (“PSUs”), provided to you as a Service Provider, is being issued under the Amended and Restated Target Corporation 2011 Long-Term Incentive Plan (the “Plan”), subject to the following terms and conditions.

1.    Definitions. Except as otherwise provided in this Agreement, the defined terms used in this Agreement shall have the same meaning as in the Plan. The term “Committee” shall also include those persons to whom authority has been delegated under the Plan.

2.    Grant of PSUs. Subject to the relevant terms of the Plan and this Agreement, as of the Grant Date, the Company has granted the Executive the number of PSUs set forth in the Award Letter (the “Goal Payout”). The maximum number of Shares that may be earned is equal to 175% of the Goal Payout (the “Maximum Payout”). The number of Shares actually earned, if any, shall depend on the Company’s performance during the period comprised of the Company’s three consecutive fiscal years beginning with the first full fiscal year commencing after the Grant Date (the “Performance Period”).

3.    Minimum Performance Condition. Except as set forth in Section 6, as a condition to the receipt of any Shares in settlement of the Award, the Company’s earnings from continuing operations before interest expense and income taxes, excluding: (a) restructuring, exit or disposal costs under ASC 420 and ASC 712, (b) impairment charges under ASC 350 and ASC 360, and (c) benefit plan curtailment, settlement, amendment and termination gains and losses under ASC 715, must be greater than zero for the first full fiscal year of the Performance Period (the “Minimum Performance Condition”). The Committee shall determine whether the Minimum Performance Condition is satisfied as soon as practicable after completion of the first full fiscal year of the Performance Period (the “Determination Date”).

4.    Payout Formula. Except as set forth in Section 6, if the Minimum Performance Condition is satisfied, the actual number of Shares earned will be determined by the Committee pursuant to a formula established by the Committee to measure the Company’s performance during the Performance Period (the “Payout Formula”). The determination of the actual number of Shares earned, which shall not exceed the Maximum Payout, shall occur as soon as practicable after completion of the Performance Period, but in any event not later than



November 30 of the calendar year in which the Performance Period ends (the date the Committee so determines, the “Final Determination Date”). A description of the Payout Formula and the percentage of Shares to be earned, if any, for the various levels of performance will be communicated to the Executive. All decisions of the Committee regarding the application of the Payout Formula and the number of Shares earned shall be final and binding on the Executive. Except as set forth in Section 6, the Award shall be cancelled and the Executive shall have no rights hereunder if any of the following occur: (a) the Committee determines on the Determination Date that the Minimum Performance Condition has not been satisfied, (b) the Final Determination Date does not occur, or (c) the Committee determines on the Final Determination Date that no Shares have been earned.

5.    Continuous Service Requirement. In order to earn any Shares, the Executive must be continuously providing Service from the Grant Date to the end of the Performance Period, except as described in this Section and Section 6. Even if the Executive is not continuously providing Service through the end of the Performance Period, upon the occurrence of one of the events specified in Sections 5(a) through 5(d), the Shares that are earned during the Performance Period, if any, shall be paid out as provided in Section 10, in accordance with and subject to any restrictions set forth in this Agreement, the Plan or any Release Agreement that the Executive may be required to enter pursuant to this Section or Section 6. “Release Agreement” means an agreement containing a release of claims, a covenant not to engage in competitive employment, and/or other provisions deemed appropriate by the Committee in its sole discretion.

(a)    Early Retirement Date. The Executive’s Service terminates on or after the Executive’s Early Retirement Date and the Company receives a valid unrevoked Release Agreement from the Executive. “Early Retirement Date” is the date that is (i) on or prior to the Executive’s termination of Service, (ii) at or after attaining age 45 and prior to attaining age 55 and completing at least 15 years of Service (which 15 years need not be continuous), (iii) if the Executive’s termination of Service is voluntary, at least six months after the Executive commenced discussions with the Company’s Chief Executive Officer or most senior human resources executive regarding the Executive’s consideration of termination, and (iv) the following additional requirements are satisfied, to the extent applicable: (A) if the Executive’s Early Retirement Date occurs prior to the Executive’s attainment of age 48, the Executive was providing Service for at least the first 24 months of the Performance Period, (B) if the Executive’s Early Retirement Date occurs prior to the Executive’s attainment of age 52 and on or after attainment of age 48, the Executive was providing Service for at least the first 18 months of the Performance Period, and (C) if the Executive’s Early Retirement Date occurs prior to the Executive’s attainment of age 55 and on or after attainment of age 52, the Executive was providing Service for at least the first 12 months of the Performance Period.

(b)    Normal Retirement Date. The Executive’s Service terminates on or after the Executive’s Normal Retirement Date and the Company receives a valid unrevoked Release Agreement from the Executive. “Normal Retirement Date” is the date that is (i) on or prior to the Executive’s termination of Service, (ii) at or after attaining age 55 and completing at least 5 years of Service (which 5 years need not be continuous), and (iii) if the Executive’s termination of Service is voluntary, at least six months after the Executive commenced discussions with the

2.


Company’s Chief Executive Officer or most senior human resources executive regarding the Executive’s consideration of termination.

(c)    Death. The Executive’s death prior to the Executive’s termination of Service.

(d)    Disability. The Executive’s Disability (as determined by the Committee in its sole discretion, provided such determination complies with the definition of disability under Code Section 409A) prior to the Executive’s termination of Service.

6.    Change in Control.

(a)    If a Change in Control occurs prior to the Determination Date or after a Committee determination on the Determination Date that the Minimum Performance Condition has been satisfied, the Award will continue to be subject to the Continuous Service Requirement provided in Section 5, the Minimum Performance Condition shall be deemed to be satisfied and, at the end of the Performance Period, the total number of Shares earned under the Payout Formula shall be deemed to be equal to the Goal Payout, except that if, after a Change in Control and prior to the end of the Performance Period:

(i)    the Executive’s Service terminates voluntarily by the Executive for Good Reason or involuntarily without Cause, and provided that the Company has received a valid unrevoked Release Agreement from the Executive, then the total number of Shares earned under the Payout Formula shall be deemed to be equal to the Goal Payout multiplied by a fraction. The numerator of such fraction shall be the number of months that have elapsed between the Grant Date and the date of termination of Service following the Change in Control, and the denominator shall be the number of months between the Grant Date and the end of the Performance Period. Notwithstanding the foregoing in this Section 6(a)(i), the total number of Shares earned under the Payout Formula shall be deemed to be equal to the Goal Payout if, on or prior to the termination of Service under this Section 6(a)(i), the Executive meets the requirements for age, years of Service and minimum Service during the Performance Period for an “Early Retirement Date” in Section 5(a) or a “Normal Retirement Date” in Section 5(b) and the Company has received a valid unrevoked Release Agreement from the Executive.

(ii)    the Executive experiences one of the events specified in Sections 5(a) through 5(d), then the total number of Shares earned under the Payout Formula shall be deemed to be equal to the Goal Payout.

(b)    If, prior to a Change in Control, the Committee has determined on the Determination Date that the Minimum Performance Condition has not been satisfied, then the Award shall be cancelled and the Executive shall have no rights hereunder.

7.    Cause. Notwithstanding any other provisions of this Agreement to the contrary, if the Committee concludes, in its sole discretion, that the Executive’s Service was terminated in whole or in part for Cause, all of the PSUs subject to the Award shall terminate immediately and the Executive shall have no rights hereunder.


3.


8.    Other Termination; Changes of Service. If the Executive’s termination of Service occurs at any time prior to the end of the Performance Period for any reason not meeting the conditions specified in Sections 5 through 7, all of the PSUs subject to the Award shall terminate effective as of the date of termination of Service and the Executive shall have no rights hereunder. Service shall not be deemed terminated in the case of (a) any approved leave of absence, or (b) transfers among the Company and any Subsidiaries in the same Service Provider capacity; however, a termination of Service shall occur if (i) the relationship the Executive had with the Company or a Subsidiary at the Grant Date terminates, even if the Executive continues in another Service Provider capacity with the Company or a Subsidiary, or (ii) the Executive experiences a “separation from service” within the meaning of Code Section 409A.

9.    Dividend Equivalents. The Executive shall have the right to receive additional PSUs with a value equal to the regular cash dividend paid on one Share for each PSU earned pursuant to this Agreement prior to the conversion of PSUs and issuance of Shares pursuant to Section 10. The dividend equivalents will be based on the actual number of PSUs earned pursuant to this Agreement. The number of additional PSUs to be received as dividend equivalents for each PSU held shall be determined by dividing the cash dividend per share by the Fair Market Value of one Share on the dividend payment date; provided, however, that for purposes of avoiding the issuance of fractional PSUs, on each dividend payment date the additional PSUs issued as dividend equivalents shall be rounded up to the nearest whole number. All such additional PSUs received as dividend equivalents shall be subject to forfeiture in the same manner and to the same extent as the original PSUs granted hereby, and shall be converted into Shares on the basis and at the time set forth in Section 10 hereof.

10.    Time of Payout. Vested PSUs shall be converted to Shares in accordance with the Payout Formula and shall be issued as soon as practicable following the end of the Performance Period and after the Committee has determined on the Final Determination Date that they have been earned, but not later than 60 days following the Final Determination Date. The Committee in its sole discretion may accelerate or delay the distribution of any payment under this Agreement to the extent allowed or required under Code Section 409A. Payment of amounts under this Agreement are intended to comply with the requirements of Code Section 409A and this Agreement shall in all respects be administered and construed to give effect to such intent.

11.    Taxes. The Executive acknowledges that (a) the ultimate liability for any and all income tax, social insurance, payroll tax, payment on account or other tax-related withholding (“Tax-Related Items”) legally due by him or her is and remains the Executive’s responsibility and may exceed the amount actually withheld by the Company and/or a Subsidiary to which the Executive is providing Service (the “Service Recipient”) and (b) the Company and/or the Service Recipient or a former Service Recipient, as applicable, (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the PSUs, including, but not limited to, the grant, vesting and/or conversion of the PSUs and issuance of Shares; (ii) do not commit and are under no obligation to structure the terms of the grant or any aspect of the PSUs to reduce or eliminate the Executive’s liability for Tax-Related Items; (iii) may be required to withhold or account for Tax-Related Items in

4.


more than one jurisdiction if the Executive has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event; and (iv) may refuse to deliver the Shares to the Executive if he or she fails to comply with his or her obligations in connection with the Tax-Related Items as provided in this Section.

The Executive authorizes and consents to the Company and/or the Service Recipient, or their respective agents, satisfying all applicable Tax-Related Items which the Company reasonably determines are legally payable by him or her by withholding from the Shares that would otherwise be delivered to the Executive the highest number of whole Shares that the Company determines has a value less than or equal to the aggregate applicable Tax-Related Items. In lieu thereof, the Executive may elect at the time of conversion of the PSUs such other then-permitted method or combination of methods established by the Company and/or the Service Recipient to satisfy the Executive’s Tax-Related Items.

12.    Limitations on Transfer. The Award shall not be sold, assigned, transferred, exchanged or encumbered by the Executive other than pursuant to the terms of the Plan.

13.    Recoupment Provision. In the event of a restatement of the Company’s consolidated financial statements that is caused, in whole or in part, by the intentional misconduct of the Executive, the Company may take one or more of the following actions with respect to the Award, as determined by the Compensation Committee of the Board (the “Compensation Committee”) in its sole discretion, and the Executive shall be bound by such determination:

(a)    cancel all or a portion of the PSUs, whether earned or unearned, including any dividend equivalents related to the Award; and

(b)    require repayment of all or any portion of the amounts realized or received by the Executive resulting from the conversion of PSUs to Shares or the sale of Shares related to the Award.

The term “restatement” shall mean the result of revising financial statements previously filed with the Securities and Exchange Commission to reflect the correction of an error. The term “intentional misconduct” shall be limited to conduct that the Compensation Committee determines indicates intent to mislead management, the Board, or the Company’s shareholders, but shall not include good faith errors in judgment made by the Executive.

The Executive agrees that the Company may setoff any amounts it is entitled to recover under this Section against any amounts owed by the Company to the Executive under any of the Company’s deferred compensation plans to the extent permitted under Code Section 409A. The Executive further agrees that the terms of this Section shall survive the Executive’s termination of Service and any conversion of the Award into Shares. This Section 13 shall not apply, and no amounts may be recovered hereunder, following a Change in Control.

14.    No Employment Rights. Nothing in this Agreement, the Plan or the Award Letter shall confer upon the Executive any right to continued Service with the Company or any Subsidiary, as applicable, nor shall it interfere with or limit in any way any right of the Company

5.


or any Subsidiary, as applicable, to terminate the Executive’s Service at any time with or without Cause or change the Executive’s compensation, other benefits, job responsibilities or title provided in compliance with applicable local laws and permitted under the terms of the Executive’s Service contract, if any.

(a)    The Executive’s rights to vest in the PSUs or receive Shares after termination of Service shall be determined pursuant to Sections 4 through 10. Those rights and the Executive’s date of termination of Service will not be extended by any notice period mandated under local law (e.g., active service would not include a period of “garden leave” or similar notice period pursuant to local law).

(b)    This Agreement, the Plan and the Award Letter are separate from, and shall not form, any part of the contract of Service of the Executive, or affect any of the rights and obligations arising from the Service relationship between the Executive and the Company and/or the Service Recipient.

(c)    No Service Provider has a right to participate in the Plan. All decisions with respect to future grants, if any, shall be at the sole discretion of the Company and/or the Service Recipient.

(d)    The Executive will have no claim or right of action in respect of any decision, omission or discretion which may operate to the disadvantage of the Executive.

15.    Nature of Grant. In accepting the grant, the Executive acknowledges, understands, and agrees that:

(a)    the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company at any time, unless otherwise provided in the Plan and this Agreement, and any such modification, amendment, suspension or termination will not constitute a constructive or wrongful dismissal;

(b)    the PSUs are extraordinary items and are not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, pension or welfare or retirement benefits or similar payments;

(c)    in no event should the PSUs be considered as compensation for, or relating in any way to, past services for the Company or the Service Recipient, nor are the PSUs or the underlying Shares intended to replace any pension rights or compensation;

(d)    the future value of the underlying Shares is unknown and cannot be predicted with certainty;

(e)    the Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Executive’s participation in the Plan or the PSUs;


6.


(f)    no claim or entitlement to compensation or damages shall arise from forfeiture of the PSUs resulting from termination of the Executive’s Service (for any reason whatsoever and whether or not in breach of local labor laws), and in consideration of the grant of the PSUs to which the Executive is otherwise not entitled, the Executive irrevocably (i) agrees never to institute any such claim against the Company or the Service Recipient, (ii) waives the Executive’s ability, if any, to bring any such claim, and (iii) releases the Company and the Service Recipient from any such claim. If, notwithstanding the foregoing, any such claim is allowed by a court of competent jurisdiction, then, by participating in the Plan, the Executive shall be deemed irrevocably to have agreed not to pursue such claim and agrees to execute any and all documents necessary to request dismissal or withdrawal of such claims; and

(g)    the Executive is hereby advised to consult with personal tax, legal and financial advisors regarding participation in the Plan before taking any action related to the PSUs or the Plan.

16.    Governing Law; Venue; Jurisdiction; Severability. To the extent that federal laws do not otherwise control, this Agreement, the Award Letter, the Plan and all determinations made and actions taken pursuant to the Plan shall be governed by the laws of the State of Minnesota without regard to its conflicts-of-law principles and shall be construed accordingly. The exclusive forum and venue for any legal action arising out of or related to this Agreement shall be the United States District Court for the District of Minnesota, and the parties submit to the personal jurisdiction of that court. If neither subject matter nor diversity jurisdiction exists in the United States District Court for the District of Minnesota, then the exclusive forum and venue for any such action shall be the courts of the State of Minnesota located in Hennepin County, and the Executive, as a condition of this Agreement, consents to the personal jurisdiction of that court. If any provision of this Agreement, the Award Letter or the Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Agreement, the Award Letter or the Plan, and the Agreement, the Award Letter and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included.

17.    Currencies and Dates. Unless otherwise stated, all dollars specified in this Agreement and the Award Letter shall be in U.S. dollars and all dates specified in this Agreement shall be U.S. dates.

18.    Imposition of Other Requirements. The Company reserves the right to impose other requirements on the Executive’s participation in the Plan, on the PSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Executive to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.

19.    Plan and Award Letter Incorporated by Reference; Electronic Delivery. The Plan, as hereafter amended from time to time, and the Award Letter shall be deemed to be

7.


incorporated into this Agreement and are integral parts hereof. In the event there is any inconsistency between the provisions of this Agreement and the Plan, the provisions of the Plan shall govern. The Company or a third party designated by the Company may deliver to the Executive by electronic means any documents related to his or her participation in the Plan. The Executive acknowledges receipt of a copy of the Plan and the Award Letter.

[End of Agreement]

8.

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:3/11/164
For Period end:1/30/16
 List all Filings 


6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/13/24  Target Corp.                      10-K        2/03/24  131:11M
 3/08/23  Target Corp.                      10-K        1/28/23  127:12M
 3/09/22  Target Corp.                      10-K        1/29/22  124:11M
 3/10/21  Target Corp.                      10-K        1/30/21  130:12M
 4/27/16  SEC                               UPLOAD9/21/17    1:35K  Target Corp.
 3/31/16  SEC                               UPLOAD9/21/17    1:160K Target Corp.
Top
Filing Submission 0000027419-16-000043   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 9:39:17.1pm ET